Standard

Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy. / Shefer, Aleksei; Yalovaya, Alena; Tamkovich, Svetlana.

в: International Journal of Molecular Sciences, Том 23, № 16, 8845, 09.08.2022.

Результаты исследований: Научные публикации в периодических изданияхобзорная статьяРецензирование

Harvard

APA

Vancouver

Shefer A, Yalovaya A, Tamkovich S. Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy. International Journal of Molecular Sciences. 2022 авг. 9;23(16):8845. doi: 10.3390/ijms23168845

Author

Shefer, Aleksei ; Yalovaya, Alena ; Tamkovich, Svetlana. / Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy. в: International Journal of Molecular Sciences. 2022 ; Том 23, № 16.

BibTeX

@article{2322fccc65614bbbb0621c28416e6ee4,
title = "Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy",
abstract = "In women, breast cancer (BC) is the most commonly diagnosed cancer (24.5%) and the leading cause of cancer death (15.5%). Understanding how this heterogeneous disease develops and the confirm mechanisms behind tumor progression is of utmost importance. Exosomes are long-range message vesicles that mediate communication between cells in physiological conditions but also in pathology, such as breast cancer. In recent years, there has been an exponential rise in the scientific studies reporting the change in morphology and cargo of tumor-derived exosomes. Due to the transfer of biologically active molecules, such as RNA (microRNA, long non-coding RNA, mRNA, etc.) and proteins (transcription factors, enzymes, etc.) into recipient cells, these lipid bilayer 30-150 nm vesicles activate numerous signaling pathways that promote tumor development. In this review, we attempt to shed light on exosomes' involvement in breast cancer pathogenesis (including epithelial-to-mesenchymal transition (EMT), tumor cell proliferation and motility, metastatic processes, angiogenesis stimulation, and immune system repression). Moreover, the potential use of exosomes as promising diagnostic biomarkers for liquid biopsy of breast cancer is also discussed.",
keywords = "breast cancer, exosomal cargo, exosomes, liquid biopsy, microRNA, proteins",
author = "Aleksei Shefer and Alena Yalovaya and Svetlana Tamkovich",
note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",
year = "2022",
month = aug,
day = "9",
doi = "10.3390/ijms23168845",
language = "English",
volume = "23",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "16",

}

RIS

TY - JOUR

T1 - Exosomes in Breast Cancer: Involvement in Tumor Dissemination and Prospects for Liquid Biopsy

AU - Shefer, Aleksei

AU - Yalovaya, Alena

AU - Tamkovich, Svetlana

N1 - Publisher Copyright: © 2022 by the authors.

PY - 2022/8/9

Y1 - 2022/8/9

N2 - In women, breast cancer (BC) is the most commonly diagnosed cancer (24.5%) and the leading cause of cancer death (15.5%). Understanding how this heterogeneous disease develops and the confirm mechanisms behind tumor progression is of utmost importance. Exosomes are long-range message vesicles that mediate communication between cells in physiological conditions but also in pathology, such as breast cancer. In recent years, there has been an exponential rise in the scientific studies reporting the change in morphology and cargo of tumor-derived exosomes. Due to the transfer of biologically active molecules, such as RNA (microRNA, long non-coding RNA, mRNA, etc.) and proteins (transcription factors, enzymes, etc.) into recipient cells, these lipid bilayer 30-150 nm vesicles activate numerous signaling pathways that promote tumor development. In this review, we attempt to shed light on exosomes' involvement in breast cancer pathogenesis (including epithelial-to-mesenchymal transition (EMT), tumor cell proliferation and motility, metastatic processes, angiogenesis stimulation, and immune system repression). Moreover, the potential use of exosomes as promising diagnostic biomarkers for liquid biopsy of breast cancer is also discussed.

AB - In women, breast cancer (BC) is the most commonly diagnosed cancer (24.5%) and the leading cause of cancer death (15.5%). Understanding how this heterogeneous disease develops and the confirm mechanisms behind tumor progression is of utmost importance. Exosomes are long-range message vesicles that mediate communication between cells in physiological conditions but also in pathology, such as breast cancer. In recent years, there has been an exponential rise in the scientific studies reporting the change in morphology and cargo of tumor-derived exosomes. Due to the transfer of biologically active molecules, such as RNA (microRNA, long non-coding RNA, mRNA, etc.) and proteins (transcription factors, enzymes, etc.) into recipient cells, these lipid bilayer 30-150 nm vesicles activate numerous signaling pathways that promote tumor development. In this review, we attempt to shed light on exosomes' involvement in breast cancer pathogenesis (including epithelial-to-mesenchymal transition (EMT), tumor cell proliferation and motility, metastatic processes, angiogenesis stimulation, and immune system repression). Moreover, the potential use of exosomes as promising diagnostic biomarkers for liquid biopsy of breast cancer is also discussed.

KW - breast cancer

KW - exosomal cargo

KW - exosomes

KW - liquid biopsy

KW - microRNA

KW - proteins

UR - http://www.scopus.com/inward/record.url?scp=85136738248&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/c1f9edc7-c5a9-3465-b94e-d23b5bf3dbdc/

U2 - 10.3390/ijms23168845

DO - 10.3390/ijms23168845

M3 - Review article

C2 - 36012109

AN - SCOPUS:85136738248

VL - 23

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 16

M1 - 8845

ER -

ID: 37037326